Search Results
Srdan Verstovsek, MD, on Predicting Resistance to Hydroxyurea Therapy in Polycythemia Vera
PV-AIM: using machine learning to predict resistance to hydroxyurea therapy in patients with PV
Hydroxyurea Intolerance/Resistance in Polycythemia vera
Machine-learning to predict hydroxyurea failure & thromboembolic events in polycythemia vera
Rationale for VERIFY: rusfertide added to ongoing therapy in patients with polycythemia vera
Debate: Should JAK Inhibitors use be Limited to Hydroxyurea-resistant/intolerant PV Patients? - No
How Do You Treat PV Patients That Fail Hydroxyurea (HU)?
Case study: Inadequately controlled Polycythemia Vera (PV)
2nd Line Therapy for Patients Diagnosed with Polycythemia Vera (PV)
Michael Grunwald, MD, Highlights Polycythemia Vera for Rare Disease Day
Expert Perspectives: JAK Inhibitors for Polycythemia Vera
The current treatment algorithm for polycythemia vera
